Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
286.8 BRL | -.--% | -.--% | +25.27% |
05-21 | UBS Adjusts Price Target on Ecolab to $270 From $269, Maintains Buy Rating | MT |
05-16 | Everlasting momentum |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 35.41 and 31.61 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 4.57 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+25.27% | 66.74B | - | ||
+3.00% | 49.42B | A- | ||
+20.95% | 42.17B | B+ | ||
+21.48% | 26.37B | A- | ||
+10.72% | 19.17B | C+ | ||
-1.39% | 16.73B | B+ | ||
+5.73% | 15.99B | B+ | ||
-27.02% | 14.85B | A- | ||
-12.46% | 14.86B | C+ | ||
-21.11% | 13.57B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ECL Stock
- E1CL34 Stock
- Ratings Ecolab Inc.